A - I n f o s

a multi-lingual news service by, for, and about anarchists **
News in all languages
Last 30 posts (Homepage) Last two weeks' posts Our archives of old posts

The last 100 posts, according to language
Greek_ 中文 Chinese_ Castellano_ Catalan_ Deutsch_ Nederlands_ English_ Français_ Italiano_ Polski_ Português_ Russkyi_ Suomi_ Svenska_ Türkçe_ The.Supplement

The First Few Lines of The Last 10 posts in:
Castellano_ Deutsch_ Nederlands_ English_ Français_ Italiano_ Polski_ Português_ Russkyi_ Suomi_ Svenska_ Türkçe_
First few lines of all posts of last 24 hours

Links to indexes of first few lines of all posts of past 30 days | of 2002 | of 2003 | of 2004 | of 2005 | of 2006 | of 2007 | of 2008 | of 2009 | of 2010 | of 2011 | of 2012

Syndication Of A-Infos - including RDF - How to Syndicate A-Infos
Subscribe to the a-infos newsgroups

(en) France, Alternative Libertair October (#221) - Sanofi is the main shareholder (fr) [machine translation]

Date Mon, 29 Oct 2012 09:57:23 +0200


Since this summer, the direction of Sanofi, obsessed with firm profitability, considering hundreds of layoffs. Faced with the inertia of government, employee-es are organized.
Arnaud Montebourg do not hesitate to celebrate the happy surprise: Sanofi, they are "more" than 900 jobs that management is now planning to remove 2015. The minister is publicly praised, arguing that "the government's recommendations" were scrupulously observed by employers. ---- A small bite reminder: last July, the powerful pharmaceutical company announces proposed "restructuring", which involved the unions deletion of 1 500-2 500 jobs. Line of sight, the sites of Montpellier and Toulouse (industry research), support functions (services, shopping, etc..) And its subsidiary Sanofi-Pasteur (vaccines). Immediately, the Minister of Productive Recovery up on his high horse. To achieve, by dint of successive setbacks, this poor result: nearly a thousand layoffs planned.

In this grim assessment is added threats that management still leaves hang over the 640-employee are the Toulouse site - excluding subcontracting and temporary, which represent roughly the same number of male and female workers. Because even if Sanofi eventually erase Toulouse redundancy scheme "official", the company continues to say that the future of the research center "remains unclear."

Redundancies stock

The pharmaceutical companies have yet through no particular difficulty. Instead, the benefits are waiting for you, since the group had approximately € 8.8 billion in profits in 2011. The purpose of the laboratory suffers no ambiguity minimize investment in research and increase still further the payment of dividends to shareholders. The company is also not his first attempt. Between 2009 and 2011, Sanofi has removed about 4,000 jobs in France, in a favorable situation yet. The rampage social nor has no boundaries. In 2010, plans were similar dismissal for example, was launched in the United States.

Again, the goal of all these "restructuring" - to use a euphemism in use - were based primarily on considerations stock, whether to upgrade the court actions or provide proof of return to investors.

Group assisted by the State

At the same time, the pharmaceutical company is overwhelmed with public funding. According to the local union CGT de Montpellier, it is 130 million euros were generously awarded to the company for the year 2011 only. Moreover, drug reimbursement by Social Security benefits also to Sanofi. The exact figures are difficult to evaluate each year, it is at least several tens of millions of dollars flowing into the coffers and the group. Nothing too shocking in the eyes of Montebourg, who considers that the laboratory is in the right. The employee-es, in turn, are determined not to give up. Since the summer of 2012 announcements, actions and events have increased. September 13 held several rallies in Montpellier, Strasbourg and Toulouse. More than 700 workers were thus gathered in the city rose to denounce the plans of employers. Sanofi's management obviously means sacrificing pharmaceutical research and development, accounting for the benefit of reasoning. Social issues mingle therefore public health problems. Manufacture and distribution of drugs are too important to be left in the hands of capitalists. Under these conditions, the prospect of moving to a public organization and self-directed research sites or development deserves attention. This is also the meaning of the press release of 19 September, signed by several organizations anticapitalist Toulouse [ 1 ].

Boris - South Paris

[ 1 ] Alternative libertarian, The Alternative, Convergences and alternative Fase, JI ZIP
_________________________________________
A - I N F O S N E W S S E R V I C E
By, For, and About Anarchists
Send news reports to A-infos-en mailing list
A-infos-en@ainfos.ca
Subscribe/Unsubscribe http://ainfos.ca/cgi-bin/mailman/listinfo/a-infos-en
Archive: http://ainfos.ca/en


A-Infos Information Center